The acquisition of Ellipse Technologies by NuVasive for $410 million—representing a staggering 10x sales multiple—remains a gold standard for orthopedic startups. While the industry saw the exit, I saw the engine behind it.
I joined Ellipse in 2012 as employee #18 to lead R&D. Over the following four years, the company doubled its business annually by executing a high-stakes playbook. Below are the 10 cultural pillars that defined the Ellipse DNA and enabled its remarkable growth.
1. Master the Pivot
Ellipse didn’t start in orthopedics; it began as a cardiac spin-off focused on bariatrics. When the regulatory path for gastric devices grew too steep, Chairman Mike Henson executed a brilliant pivot. By repurposing spinning magnet technology for limb lengthening and spinal deformity, the team went from a "timeout" to the first spine implant in just 23 months.
2. Take the "Moon Shot"
Avoid the "incremental trap." Many startups settle for a slightly different coating or a new color. Ellipse swung for the fences, using remote-control magnet technology to solve complex clinical problems that had no existing solution. A bold approach creates a "pull" from the market rather than a "pu...
